InvestorsHub Logo
Followers 155
Posts 12584
Boards Moderated 0
Alias Born 12/29/2013

Re: Simme post# 85164

Monday, 07/28/2014 6:30:02 PM

Monday, July 28, 2014 6:30:02 PM

Post# of 211436
Once DEWM gets Berlin cleaned up it will be a PR free for all. We will find out what they have been up to in the last 90 days. Dewmar International BMC Inc (OTCQB: DEWM) (May 26, 2014) Excerpt: Malone Bailey, LLP of Houston, Texas; front firm for engagement of all quarterly and annual reviews and audit filings for Dewmar; is said to have prepared and submitted on Thursday April 17, 2014 the Financial Statements FYE December 31, 2013. The provided financial statements explain the qualification for the OTC Pink Current Information tier remains (per FYE 2013) in good standing. The following segments of United States Securities and Exchange Commission Washington D.C. 20549, FORM 10-K, have been deemed adequate and standing: Balance Sheet; Statements of Income; Statements of Cash Flow; and supporting Financial Statement notes. However, it is purported that due to conflicting information between Dewmar and data received from Berlin Stock Exchange and/or other entities, Statements of Stockholders’ Equity (Deficit) cannot be publicly disclosed until data deficiencies cohere. Therefore, the FORM 10-K shall not be publicly posted until said data binds. Currently, no suspense date for modification is set. Unfortunately, this affects the Quarterly filings as well. Due to the nature and reasoning supporting the SEC ‘hold’ status, Dewmar International BMC Inc will not be held accountable nor penalized for any violation pursuant to Rule 144(c)(2) under the Securities Act of 1993. Without disclosing details, it is said that per Annual Statement FYE 2013, Dewmar Net Revenue has increased a substantial 124% from previous FORM 10-K, which includes online product sales. Quarterly balances, as compared to previous September 31, 2013 FORM 10-Q, Net Revenue has increased a substantial 562% (subject to adjustment upon completion of 4th quarter FYE 2013). Excerpt.